Back
AptarGroup Vs. Perspective Therapeutics Industry Stock Comparison
Buy
55
ATR
AptarGroup
Last Price:
170.31
Seasonality Move:
3.31%
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.34
Seasonality Move:
26.28%
Buy
55
AptarGroup (ATR)
is a Buy
Is AptarGroup a Buy, Sell or Hold?
- The current AptarGroup [ATR] share price is $168.26. The Score for ATR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ATR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $12.19. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATR Stock Price Chart
What is AptarGroup's stock price today?
-
The AptarGroup share price today is $168.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATR is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $12.19
The current trend is relatively stagnant and CATX is experiencing slight selling pressure.
ATR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.03 | Buy |
| Relative Strength Index (14 RSI): | 61.38 | Buy |
| Chaikin Money Flow: | -178913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (160.4 - 168.76) | Buy |
| Bollinger Bands (100): | (143.07 - 160.51) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 46.93 | Sell |
| Chaikin Money Flow: | -154562 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.92 - 13.12) | Sell |
| Bollinger Bands (100): | (11.23 - 14.35) | Sell |
ATR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 168.48 | Sell |
| 20-day SMA: | 165.8 | Buy |
| 50-day SMA: | 158.91 | Buy |
| 200-day SMA: | 146.52 | Buy |
| 8-day EMA: | 168.22 | Buy |
| 20-day EMA: | 165.81 | Buy |
| 50-day EMA: | 160.13 | Buy |
| 200-day EMA: | 147.12 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.85 | Buy |
| 20-day SMA: | 12.37 | Sell |
| 50-day SMA: | 13.45 | Sell |
| 200-day SMA: | 12.59 | Sell |
| 8-day EMA: | 12 | Buy |
| 20-day EMA: | 12.31 | Sell |
| 50-day EMA: | 12.84 | Sell |
| 200-day EMA: | 11.76 | Buy |
AptarGroup Earnings Growth & ATR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.53 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
AptarGroup Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||